☆ 4.6 Editorial Material

A watershed in the understanding of membranous nephropathy

NATURE REVIEWS NEPHROLOGY (2009)

期刊

NATURE REVIEWS NEPHROLOGY

卷 5, 期 11, 页码 617-618

出版社

NATURE PUBLISHING GROUP

DOI: 10.1038/nrneph.2009.167

关键词

-

类别

Urology & Nephrology

向作者/读者索取更多资源

Protocol

Reagent

摘要

proof has at last been provided that idiopathic membranous nephropathy is caused by autoantibodies to proteins expressed by podocytes. The discovery that autoantibodies to the M-type secretory phospholipase A2 receptor were present in most individuals affected by the condition opens a new era for the management of membranous nephropathy.

作者

我是这篇论文的作者

点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6

评分不足

次要评分

新颖性

-

重要性

-

科学严谨性

-

评价这篇论文

推荐

Article Oncology

Construction of a Nomogram Discriminating Malignancy-Associated Membranous Nephropathy From Idiopathic Membranous Nephropathy: A Retrospective Study

Ting Wang, Wei Yu, Feng Wu, Yiding Zhang, Jin Shang, Zhanzheng Zhao

Summary: A discriminant model based on demographic information and laboratory parameters was developed to efficiently distinguish MMN and IMN, with a diagnostic power of 0.860 and 0.870 in the training and test groups, respectively. The model showed good calibration capability and clinical utility, highlighting the importance of carefully monitoring patients with higher scores for the presence of tumors in clinical practice.

FRONTIERS IN ONCOLOGY (2022)

添加到收藏夹

Review Immunology

Pediatric membranous nephropathy: In the novel antigens era

Guoping Huang, Fei Liu, Ling Yu, Jingjing Wang, Junyi Chen, Jianhua Mao

Summary: Membranous nephropathy (MN) is a glomerular disease characterized by immune complex deposition and capillary wall thickening. MN in pediatric population has a lower incidence and more secondary factors compared to adult patients. Novel antigens have been identified in recent years, representing different clinical and pathologic findings. In-depth research is needed to understand the outcomes and pathophysiology of novel antigen-associated MN, and targeted treatment options are being developed for patients of different ages.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Review Biochemistry & Molecular Biology

Mechanisms of Primary Membranous Nephropathy

Yan Gu, Hui Xu, Damu Tang

Summary: Membranous nephropathy is an autoimmune disease affecting the kidney glomerulus, with around 30% of cases progressing to end-stage renal disease. Recent studies have identified the significance of autoantibodies like PLA2R and THSD7A in diagnosing and treating MN, while the discovery of new antigens like NELL-1 may further elucidate the full spectrum of PMN.

BIOMOLECULES (2021)

添加到收藏夹

Article Immunology

Rituximab Immunomonitoring Predicts Remission in Membranous Nephropathy

Maxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, Thomas Crepin, Sylvia Benzaken, Kevin Zorzi, Vincent Esnault, Vesna Brglez, Barbara Seitz-Polski

Summary: In patients with primary membranous nephropathy (pMN), residual rituximab levels at month-3 are identified as a novel early predictor of treatment remission at month-6 and month-12. Low serum albumin and high anti-PLA2R1 titers are associated with reduced likelihood of remission. High baseline proteinuria and undetectable rituximab levels at month-3 are independent risk factors for treatment failure at month-6, while high baseline weight and undetectable rituximab levels at month-3 are independent risk factors for treatment failure at month-12. Serum albumin at baseline is a predictive factor for rituximab levels at month-3.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Review Immunology

Advances in the Management of Primary Membranous Nephropathy and Rituximab-Refractory Membranous Nephropathy

Maxime Teisseyre, Marion Cremoni, Sonia Boyer-Suavet, Caroline Ruetsch, Daisy Graca, Vincent L. M. Esnault, Vesna Brglez, Barbara Seitz-Polski

Summary: Primary membranous nephropathy (pMN) is an autoimmune disease characterized by damage to the glomerular basement membrane due to auto-antibodies. The conventional treatment approach for pMN involves uniform management, regardless of disease severity. However, recent advances have led to a more personalized management based on prognostic markers. Rituximab, an immunosuppressive drug, has shown to be effective in achieving remission in a majority of patients with pMN. However, there are cases of rituximab resistance, which pose challenges to treatment. Immunomonitoring may aid in overcoming treatment resistance by identifying possible causes and adjusting the treatment accordingly.

FRONTIERS IN IMMUNOLOGY (2022)

添加到收藏夹

Article Immunology

Cytokines network in primary membranous nephropathy

Qihan Zhao, Haoran Dai, Yuehong Hu, Hanxue Jiang, Zhendong Feng, Wenbin Liu, Zhaocheng Dong, Xinyue Tang, Fanyu Hou, Hongliang Rui, Baoli Liu

Summary: This article explores the role of cytokines in primary membranous nephropathy (PMN), and clarifies whether inflammation is involved in its pathological process. It also suggests certain cytokines as potential biomarkers or therapeutic targets.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

添加到收藏夹

Review Urology & Nephrology

New 'Antigens' in Membranous Nephropathy

Sanjeev Sethi

Summary: Membranous nephropathy is a disease caused by immune complex deposition along the glomerular basement membrane, with PLA2R and THSD7A being the main antigens. New mass spectrometry techniques have led to the discovery of four novel types of MN, each with distinct clinical and pathologic features. Additional studies are needed to understand the pathophysiology, treatment response, and outcomes of these new MN subtypes.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2021)

添加到收藏夹

Article Urology & Nephrology

Mapping antigens of membranous nephropathy: almost there

Sanjeev Sethi, Benjamin Madden

Summary: Membranous nephropathy (MN) is characterized by subepithelial accumulation of immune complexes along the glomerular basement membranes. Recent advances have led to the discovery of 7 novel putative antigens and the identification of target antigens in approximately 90% of MN cases. This study also proposes a working algorithm for evaluating the target antigens in MN, along with the description of 10 other novel putative antigens.

KIDNEY INTERNATIONAL (2023)

添加到收藏夹

Article Urology & Nephrology

NELL1 is a target antigen in malignancy-associated membranous nephropathy

Tiffany N. Caza, Samar I. Hassen, Zeljko Dvanajscak, Michael Kuperman, Rick Edmondson, Christian Herzog, Aaron Storey, John Arthur, L. Nicholas Cossey, Shree G. Sharma, Daniel J. Kenan, Christopher P. Larsen

Summary: Patients with membranous nephropathy associated with malignancy were found to have unique NELL1 immune complexes in kidney biopsy tissue, with characteristic histopathology of incomplete capillary loop staining and IgG1 predominance. These NELL1-positive cases also showed a higher association with concurrent malignancy compared to other known types of membranous nephropathy.

KIDNEY INTERNATIONAL (2021)

添加到收藏夹

Article Urology & Nephrology

Segmental Membranous Glomerulopathy in Adults

Shuangshuang Zhu, Xiaoting Liu, Shuling Yue, Bei Luo, Zhen Song, Xiaomeng Xu, Lin Wang, Xiaotao Hou, Kongshan Li, Qiming Liang, Zheya Zhou, Wenfang Chen, Lei Zheng

Summary: This study investigated the prevalence and clinicopathological features of segmental membranous glomerulopathy (SMGN) in adults. The results showed that SMGN is a relatively rare pathological type, mainly occurring in females with a median age of 41.5 years. 33.1% of patients had full nephrotic syndrome, absence of PLA2R and THSD7A, 43.0% were NELL1-positive, and mainly stage I or II membranous nephropathy (MN) alterations (83.8%).

KIDNEY DISEASES (2023)

添加到收藏夹

Article Medicine, General & Internal

A Target Antigene-Based Approach to the Classification of Membranous Nephropathy

Shane A. Bobart, Shahrzad Tehranian, Sanjeev Sethi, Mariam P. Alexander, Samih H. Nasr, Casal Moura Marta, Julie A. Vrana, Samar Said, Callen D. Giesen, John C. Lieske, Fernando C. Fervenza, An S. De Vriese

Summary: This study described the clinical and pathological phenotype of membranous nephropathy associated with different target antigens. The distinction between primary and secondary MN was found to have limitations, and a refined terminology combining target antigen and associated disease was proposed for better classification.

MAYO CLINIC PROCEEDINGS (2021)

添加到收藏夹

Article Urology & Nephrology

Discovery of seven novel putative antigens in membranous and membranous lupus nephritis identified by mass spectrometry

Tiffany N. Caza, Aaron J. Storey, Samar I. Hassen, Christian Herzog, Rick D. Edmondson, John M. Arthur, Daniel J. Kenan, Christopher P. Larsen

Summary: Multiple new antigenic targets have been identified in PLA2R-/THSD7A-/EXT-/NELL1-quadruple negative MN biopsies through mass spectrometry of immune complexes. These discoveries expand our understanding of the disease and may contribute to the development of new diagnostic approaches.

KIDNEY INTERNATIONAL (2023)

添加到收藏夹

Article Urology & Nephrology

Netrin G1 Is a Novel Target Antigen in Primary Membranous Nephropathy

Linda Reinhard, Maya Machalitza, Thorsten Wiech, Hermann-Josef Groene, Moritz Lasse, Markus Rinschen, Nicoletta Ferru, Jan Braesen, Friederike Droemann, Peter Rob, Sanjeev Sethi, Elion Hoxha, Rolf Stahl

Summary: This study identified a novel target antigen, Netrin G1 (NTNG1), in primary membranous nephropathy (MN) and confirmed the presence of NTNG1 autoantibodies in MN patients. The findings expand our understanding of the pathogenesis in MN and have important implications for further research on the clinical role of NTNG1 autoantibodies.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

添加到收藏夹

Review Immunology

Autoantibodies in the Diagnosis, Monitoring, and Treatment of Membranous Nephropathy

Vladimir Tesar, Zdenka Hruskova

Summary: The discovery of anti-podocyte antibodies in primary membranous nephropathy has significantly impacted the diagnosis, treatment, and prognosis of this disease. Evaluation of serum levels of these antibodies allows for non-invasive diagnosis, prediction of renal outcomes, and personalized treatment. However, further research is needed to understand the relationship between anti-podocyte antibodies and cancer, the risk of MN recurrence before renal transplantation, and the implications of antibodies against minor antigens.

FRONTIERS IN IMMUNOLOGY (2021)

添加到收藏夹

Article Immunology

Novel treatment options in rituximab-resistant membranous nephropathy patients

Elham Ahmadian, Seyed Mahdi Hosseiniyan Khatibi, Sepideh Zununi Vahed, Mohammadreza Ardalan

Summary: Rituximab has become the first-line therapeutic agent for non-severe cases of primary membranous nephropathy to achieve remission of proteinuria. However, approximately 20-40% of patients do not respond to rituximab treatment, leading to the need for new biologic agents such as second-generation anti-CD20 antibodies, plasma cell depleting agents, and proteasome inhibition.

INTERNATIONAL IMMUNOPHARMACOLOGY (2022)

添加到收藏夹

Article Urology & Nephrology

Eculizumab use in a tertiary care nephrology center: data from the Vienna TMA cohort

Christof Aigner, Martina Gaggl, Gunar Stemer, Michael Eder, Georg Bohmig, Renate Kain, Zoltan Prohaszka, Nora Garam, Dorottya Csuka, Raute Sunder-Plassmann, Leah Charlotte Piggott, Natalja Haninger-Vacariu, Alice Schmidt, Gere Sunder-Plassmann

Summary: The study examined the indications and outcomes of eculizumab therapy in a tertiary care nephrology center, showing that it is the treatment of choice for patients with complement gene-variant mediated TMA who do not respond to plasma therapy. However, response rates to therapy were lower in patients with secondary TMA and C3 glomerulopathy, highlighting the importance of carefully considering the decision to start therapy.

JOURNAL OF NEPHROLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

Murine Ex Vivo Cultured Alveolar Macrophages Provide a Novel Tool to Study Tissue-Resident Macrophage Behavior and Function

Anna-Dorothea Gorki, Dorte Symmank, Sophie Zahalka, Karin Lakovits, Anastasiya Hladik, Brigitte Langer, Barbara Maurer, Veronika Sexl, Renate Kain, Sylvia Knapp

Summary: This study proposes a novel culture model for studying and expanding murine primary alveolar macrophages (AMs) in vitro over several months. The cultured AMs maintain typical features and surface markers, and exhibit similar functions and transcriptional profile to primary AMs. When transferred into AM-deficient mice, the cultured AMs efficiently engraft in the lung and perform key macrophage functions.

AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2022)

添加到收藏夹

Article Biochemistry & Molecular Biology

An adapted passive model of anti-MPO dependent crescentic glomerulonephritis reveals matrix dysregulation and is amenable to modulation by CXCR4 inhibition

Cherine Abou Faycal, Andre Oszwald, Tobias Feilen, Miguel Cosenza-Contreras, Oliver Schilling, Thomas Loustau, Fanny Steinbach, Helga Schachner, Brigitte Langer, Peter Heeringa, Andrew J. Rees, Gertraud Orend, Renate Kain

Summary: This study established a severe FNGN mouse model by combined administration of antibodies and bacterial lipopolysaccharides, which replicated acute injury and investigated the process of glomerular and interstitial scarring. Mass-spectrometric proteome analysis revealed detailed changes in the extracellular matrix and cells. The study observed tissue infiltration by neutrophils, macrophages, T cells, and myofibroblasts.

MATRIX BIOLOGY (2022)

添加到收藏夹

Article Cardiac & Cardiovascular Systems

The expression and role of tenascin C in abdominal aortic aneurysm formation and progression

Felix Nagel, Anne-Kristin Schaefer, Ines Fonseca Goncalves, Eylem Acar, Andre Oszwald, Philipp Kaiser, Renate Kain, Karola Trescher, Wolf H. Eilenberg, Christine Brostjan, David Santer, Attila Kiss, Bruno K. Podesser

Summary: This study found that TNC may play an important role in the formation and progression of AAA, with TNC knockout mice showing lower disease diameters compared to wild-type mice. In human cells, TNC incubation resulted in the expression of remodeling-associated proteins.

INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY (2022)

添加到收藏夹

Editorial Material Urology & Nephrology

A View on Cathepsin C as a Target for Therapy in AAV

Renate Kain, Maja C. Nackenhorst

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2022)

添加到收藏夹

Letter Urology & Nephrology

First case of atypical haemolytic uraemic syndrome following COVID-19 vaccination with BNT162b2

Sophie H. Schmidt, Alice Schmidt, Christof Aigner, Renate Kain, Gere Sunder-Plassmann

CLINICAL KIDNEY JOURNAL (2022)

添加到收藏夹

Article Rheumatology

Safety and immunogenicity of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases compared with healthy controls

Felix Kartnig, Daniel Mrak, Elisabeth Simader, Selma Tobudic, Helga Radner, Peter Mandl, Lisa Goeschl, Nikolaus Hommer, Margareta Mayer, Philipp Hofer, Thomas Hummel, Thomas Deimel, Irina Gessl, Antonia Puchner, Andreas Kerschbaumer, Renate Thalhammer, Alessandra Handisurya, Renate Kain, Stefan Winkler, Josef S. Smolen, Karin Stiasny, Thomas Perkmann, Helmuth Haslacher, Judith H. Aberle, Daniel Aletaha, Leonhard X. Heinz, Daniela Sieghart, Michael Bonelli

Summary: This clinical trial evaluated the immunogenicity and safety of a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases (IMIDs). The results showed that the third vaccination had good immunogenicity and safety in these patients, but the effects of immunomodulatory therapy should be considered.

ANNALS OF THE RHEUMATIC DISEASES (2023)

添加到收藏夹

Article Immunology

Accelerated waning of immune responses to a third COVID-19 vaccination in patients with immune-mediated inflammatory diseases

Daniel Mrak, Felix Kartnig, Daniela Sieghart, Elisabeth Simader, Helga Radner, Peter Mandl, Lisa Goeschl, Philipp Hofer, Thomas Deimel, Irina Gessl, Renate Kain, Stefan Winkler, Josef S. Smolen, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha, Leonhard X. Heinz, Michael Bonelli

Summary: A study found that patients under immunosuppression experienced a rapid decline in antibodies after the third COVID-19 vaccine dose, and it remains unclear whether immunosuppressive therapy affects immune responses. Monitoring the immune response and adverse events in 50 immunosuppressed patients and 42 healthy controls, it was observed that immunosuppressed patients had significantly lower antibody levels, suggesting the need for an early fourth vaccination.

JOURNAL OF AUTOIMMUNITY (2023)

添加到收藏夹

Article Hematology

Duodenal macrophages control dietary iron absorption via local degradation of transferrin

Nyamdelger Sukhbaatar, Maria Schoeller, Stephanie Deborah Fritsch, Monika Linke, Stefanie Horer, Manuela Traeger, Mario Mazic, Stephan Forisch, Karine Gonzales, Jan Pascal Kahler, Carina Binder, Caroline Lassnig, Birgit Strobl, Mathias Mueller, Barbara Scheiber-Mojdehkar, Claudia Gundacker, Stefanie Dabsch, Renate Kain, Markus Hengstschlaeger, Steven H. L. Verhelst, Guenter Weiss, Igor Theurl, Thomas Weichhart

Summary: Iron is a crucial cellular metal for various physiological functions. Its absorption from the diet and transport by transferrin is important for iron metabolism. Regulation of iron absorption and transfer remains poorly understood. In this study, macrophage-specific deletion of Tsc2, a negative regulator of mTORC1, in mice led to defects in iron metabolism, including impaired erythropoiesis and reduced Tf saturation. This was due to an iron import block in the duodenal epithelial cells. Activation of mTORC1 in duodenal macrophages promoted Tf degradation, while depletion of macrophages increased Tf levels. Inhibition of mTORC1 or serine protease activity restored Tf levels in the Tsc2-deficient mice. These findings suggest that duodenal macrophages regulate iron transfer by controlling Tf availability.

BLOOD (2023)

添加到收藏夹

Article Virology

Multifactorial White Matter Damage in the Acute Phase and Pre-Existing Conditions May Drive Cognitive Dysfunction after SARS-CoV-2 Infection: Neuropathology-Based Evidence

Ellen Gelpi, Sigrid Klotz, Miriam Beyerle, Sven Wischnewski, Verena Harter, Harald Kirschner, Katharina Stolz, Christoph Reisinger, Elisabeth Lindeck-Pozza, Alexander Zoufaly, Marlene Leoni, Gregor Gorkiewicz, Martin Zacharias, Christine Haberler, Johannes Hainfellner, Adelheid Woehrer, Simon Hametner, Thomas Roetzer, Till Voigtlaender, Gerda Ricken, Verena Endmayr, Carmen Haider, Judith Ludwig, Andrea Polt, Gloria Wilk, Susanne Schmid, Irene Erben, Anita Nguyen, Susanna Lang, Ingrid Simonitsch-Klupp, Christoph Kornauth, Maja Nackenhorst, Johannes Klaeger, Renate Kain, Andreas Chott, Richard Wasicky, Robert Krause, Guenter Weiss, Judith Loeffler-Rag, Thomas Berger, Patrizia Moser, Afshin Soleiman, Martin Asslaber, Roland Sedivy, Nikolaus Klupp, Martin Klimpfinger, Daniele Risser, Herbert Budka, Lucas Schirmer, Anne-Katrin Probstel, Romana Hoeftberger

Summary: We conducted a neuropathological analysis on 32 patients who died from COVID-19 in Austria between 2020 and 2021. The results showed diffuse white matter damage and microglial activation in all cases, indicating indirect brain damage rather than direct virus-specific damage. Inflammatory changes and vascular pathologies were also observed, along with silent neurodegenerative pathologies in elderly patients. These findings align with experimental data on SARS-CoV-2-related brain damage and provide a better understanding of the mechanisms underlying neurological symptoms after COVID-19.

VIRUSES-BASEL (2023)

添加到收藏夹

Article Genetics & Heredity

Severe nephrotic syndrome and early end-stage diabetic kidney disease in ABCC8-MODY12: A case report

Sophie H. H. Schmidt, Ursula Barnas, Christof Aigner, Peter Wolf, Nicolas Kozakowski, Renate Kain, Thomas Scherer, Alice Schmidt, Gere Sunder-Plassmann

Summary: A 24-year-old man with diabetes mellitus and severe proteinuria was diagnosed with ABCC8-MODY12. Kidney biopsy showed nodular glomerulosclerosis. Dialysis and treatment with a sulfonylurea improved his glycemic control. This case highlights the risk of early-onset and severe diabetic kidney disease in patients with ABCC8-MODY12 and emphasizes the importance of timely genetic diagnosis for proper treatment and prevention of late sequelae of diabetes.

FRONTIERS IN GENETICS (2023)

添加到收藏夹

Article Urology & Nephrology

Digital Spatial Profiling of Glomerular Gene Expression in Pauci-Immune Focal Necrotizing Glomerulonephritis

Andre Oszwald, Raul A. Mejia-Pedroza, Helga Schachner, Christof Aigner, Andrew Rees, Renate Kain

Summary: The study used the DSP platform to analyze protein and mRNA expression in biopsies from patients with piFNGN, revealing gene expression profiles that are related to the morphological evolution of glomerular injury.

KIDNEY360 (2023)

添加到收藏夹

Meeting Abstract Rheumatology

Reduced Humoral but Maintained Cellular Immune Response to a 3rd COVID-19 Vaccination in Patients with Immune-Mediated Inflammatory Diseases as Compared to Healthy Controls over a 3-months Observational Period

Daniel Mrak, Felix Kartnig, Daniela Sieghart, Elisabeth Simader, Helga Radner, Peter Mandl, Lisa Goschl, Philipp Hofer, Thomas Hummel, Thomas Deimel, Irina Gessl, Renate Kain, Stefan Winkler, Josef Smolen, Thomas Perkmann, Helmuth Haslacher, Daniel Aletaha, Leonhard Heinz, Michael Bonelli

ARTHRITIS & RHEUMATOLOGY (2022)

添加到收藏夹

Article Surgery

Single Donor Infusion of S-Nitroso-Human-Serum-Albumin Attenuates Cardiac Isograft Fibrosis and Preserves Myocardial Micro-RNA-126-3p in a Murine Heterotopic Heart Transplant Model

Anne-Kristin Schaefer, Attila Kiss, Andre Oszwald, Felix Nagel, Eylem Acar, Arezu Aliabadi-Zuckermann, Matthias Hackl, Andreas Zuckermann, Renate Kain, Andrzej Jakubowski, Peter Ferdinandy, Seth Hallstroem, Bruno K. Podesser

Summary: This study assessed the effects of a nitric oxide donor on graft injury after heart transplantation. The results showed that pre-treatment of the donor with S-NO-HSA reduced fibrosis and preserved levels of miR-126-3p and GATA2 in the myocardium.

TRANSPLANT INTERNATIONAL (2022)

添加到收藏夹

Article Urology & Nephrology

Computer-assisted evaluation enhances the quantification of interstitial fibrosis in renal implantation biopsies, measures differences between frozen and paraffin sections, and predicts delayed graft function

Mladen Pavlovic, Andre Oszwald, Zeljko Kikic, Maja Carina Nackenhorst, Renate Kain, Nicolas Kozakowski

Summary: (English Summary:) This study used digital image analysis (DIA) to evaluate interstitial fibrosis in pre-implantation biopsies. The results showed that frozen sections displayed a broader interstitial area compared to paraffin sections, and DIA was found to be more consistent and accurate in evaluating interstitial fibrosis. Additionally, DIA of interstitial fibrosis in paraffin sections was identified as an independent predictor for delayed graft function.

JOURNAL OF NEPHROLOGY (2022)

添加到收藏夹

暂无数据

© Peeref 2019-2024. All rights reserved.